Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 772 participants.

Also called NCT00965406

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 772 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT00965406
Other papers using this trial's data
  • One-Year Outcome of Intensive Insulin Therapy Combined to Glucose-Insulin-Potassium in Acute Coronary Syndrome: A Randomized Controlled Study Journal of the American Heart Association, 2017-11-14 DOI, PubMed 29138181, PMC5721763 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Tunisia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT00965406. Randomized; single masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
Condition
Acute Coronary Syndrome
Intervention (Drug)
GIK and intensive insulin therapy
Lead sponsor
University of Monastir (class: other)

Record details

Record id
cardio:ct-nct00965406
Content hash
ead08f70b77738cd1e8ea31a356084603ba614d47b9cad604a59f59a242acaca